Date Set for CombiMatrix, National Union Hearing | GenomeWeb

NEW YORK (GenomeWeb News) – CombiMatrix today said that oral arguments in its ongoing litigation with National Union Fire Insurance will be heard on Feb. 2.

The microarray and molecular diagnostics firm said that the hearing will be held at the Ninth Circuit Court of Appeals in Pasadena, Calif., and each side will have 15 minutes to make arguments in support of briefs that were filed earlier.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.